The Neuroendocrine Tumor Research Foundation (NETRF) is pleased to announce its request for proposals (RFP) for breakthrough “Accelerator Grants” to advance its mission of curing neuroendocrine cancers. With these grants, NETRF is launching an ambitious global research effort focusing on neuroendocrine tumors (NETs).
NETRF is seeking proposals for significant research projects on NETs, with grant awards of up to $1.2 million each over four years.
“NETRF seeks to fund the most dedicated teams and robust proposals to transform the landscape of NET research,” said Lauren Erb, NETRF Director of Research. Inspired by the generous funding received from the Margie and Robert E. Petersen Foundation, NETRF developed the "Accelerator Grants" as a tribute to automobile publishing giant Robert E. Petersen, who passed away from neuroendocrine cancer in 2007.
“We understand that strong, peer-reviewed research takes time, but we also understand the urgency that our patients and families feel,” said Ron Hollander, NETRF Executive Director. “Our commitment is to reach out to researchers internationally to bring the best ideas and attract leading investigators to hopefully move our drive for better treatments and cures into the fast lane.”
Letters of intent are due by October 14, 2016, and full applications are due by November 18, 2016. Funding for approved projects will begin in early 2017.
To read more and/or to apply, please click here to be taken to NETRF's site.